Adicet Bio, Inc. announced the appointment of Michael G. Kauffman, M.D., Ph.D., to its Board of Directors. Dr. Kauffman joins the Adicet board with over 20 years of experience in the life sciences industry, including expertise in preclinical research, clinical development and regulatory strategy. Currently, he is a board member for Karyopharm Therapeutics, Verastem Oncology and Kezar Life Sciences. Most recently, Dr. Kauffman served as the co-founder and Chief Executive Officer of Karyopharm.